Nifty reclaims 200 WMA; eyes further gains as key resistance shapes next move
· ET Stocks, Economic Times Markets
Indian equity markets rebounded 2.78%, with the Nifty reclaiming its crucial 200-week moving average. However, weak momentum indicators and overhead resistance warrant caution. Banking, metal, media, pharma and IT stocks show relative strength. Investors should monitor key support levels, prioritise fundamentally strong stocks and maintain disciplined risk management strategies.
The analysis
Because the driver here is macro rather than company-specific, the read-through is to index-level positioning rather than to any single name — correlations tend to rise when the whole market faces the same signal.
Market context
- A market-wide development: it reaches beyond any single stock.
- Sectors in the story: Pharma & Healthcare.
Pharma & Healthcare
1M -0.6% · 3M -0.9%
Sector moves are the average of the stocks we track in each sector.
In this story
Related coverage
Pharma company Gufic buys Lodha Avalon duplex in Juhu for ₹236 crore
Nifty Pharma index hits record high; Sun, Laurus, Zydus, Sai rally up to 6%
Regulator orders Sun Pharma to shut Assam plant over eye-drop quality lapses; what you should know
Q2 Results Live: Varun Beverages Q3 Net Profit Rises 14% YoY; Reliance Slips, Sun Pharma Gains Ahead Of Earnings
Sun Pharma Q2 profit falls 36% as litigation costs hit earnings